Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459946) titled 'Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Jiazhen Yin
Condition:
Diabetic Nephropathy Type 2
Chronic Renal Failure/ Kidney Disease
Intervention:
Drug: Jiajian Yishen Xiaozheng Qufeng Granules
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 12, 2026
...